Acebrophylline API – Trusted Respiratory Active Ingredient for Global Pharma Formulations
Acebrophylline __A Comprehensive Overview of a Modern Bronchodilator API
Respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) continue to affect millions of people worldwide. The demand for effective bronchodilators and anti-inflammatory agents has led to the development of advanced pharmaceutical compounds that improve breathing function and reduce airway inflammation. One such important Active Pharmaceutical Ingredient (API) widely used in respiratory formulations is Acebrophylline.
At Swapnroop Drugs & Pharmaceuticals, we specialize in the manufacturing and supply of high-quality pharmaceutical APIs, including Acebrophylline, ensuring reliability, regulatory compliance, and consistent product quality for pharmaceutical companies across global markets.
What is Acebrophylline?
Acebrophylline is a bronchodilator and mucoregulator used primarily in the treatment of respiratory disorders such as:
Bronchial Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Chronic Bronchitis
Respiratory inflammation disorders
Acebrophylline is chemically derived from theophylline-7-acetic acid and ambroxol, combining bronchodilatory and mucolytic properties. This dual mechanism makes it highly effective in improving airway function and reducing respiratory inflammation.
Basic Chemical Information
Chemical Name: Acebrophylline
CAS Number: 4511-14-0
Molecular Formula: C16H18N4O4
Molecular Weight: 330.34 g/mol
Drug Class: Bronchodilator / Mucoregulator
Acebrophylline appears as a white to off-white crystalline powder and is widely used in pharmaceutical tablet, capsule, and syrup formulations.
Mechanism of Action
Acebrophylline works through a multi-functional mechanism, making it a powerful therapeutic option in respiratory treatment.
1. Bronchodilation
Acebrophylline relaxes the smooth muscles of the bronchial airways. This leads to:
Expansion of bronchial passages
Improved airflow to the lungs
Reduced breathing difficulty
2. Anti-inflammatory Activity
Respiratory diseases are often associated with inflammation in the bronchial tubes. Acebrophylline helps reduce:
Inflammatory mediators
Airway swelling
Bronchial hypersensitivity
3. Mucolytic Effect
Acebrophylline reduces mucus viscosity and helps remove accumulated mucus from the respiratory tract. This improves lung function and makes breathing easier for patients.
Therapeutic Applications of Acebrophylline
Acebrophylline is widely used in the pharmaceutical industry for the formulation of medications designed to treat respiratory diseases.
1 Asthma Treatment
Acebrophylline helps reduce bronchial constriction and inflammation, allowing patients with asthma to breathe more comfortably.
2 Chronic Obstructive Pulmonary Disease (COPD)
COPD is a long-term lung condition that restricts airflow. Acebrophylline improves lung capacity and reduces symptoms such as coughing and wheezing.
3 Chronic Bronchitis
Patients suffering from chronic bronchitis experience excessive mucus production. Acebrophylline helps thin and remove mucus from the airways.
4 Respiratory Inflammation Disorders
Acebrophylline is also used to treat inflammatory airway diseases by reducing inflammatory mediators.
Advantages of Acebrophylline in Respiratory Therapy
Acebrophylline offers several advantages compared to traditional bronchodilators:
Dual Mechanism Action
It combines bronchodilator and mucolytic properties, making it more effective in respiratory management.
Improved Lung Function
The compound enhances pulmonary ventilation and oxygen flow.
Better Patient Compliance
Acebrophylline is well tolerated and suitable for long-term respiratory treatment.
Reduced Airway Inflammation
Its anti-inflammatory properties help control chronic respiratory diseases.
Pharmaceutical Formulations
Acebrophylline is widely used in different dosage forms, including:
Tablets
Capsules
Syrups
Sustained-release formulations
These formulations allow flexible dosing depending on the severity of respiratory conditions.
Manufacturing Considerations for Acebrophylline API
Manufacturing high-quality Acebrophylline API requires strict quality control and advanced pharmaceutical processes. Key considerations include:
Raw Material Quality
High-purity starting materials ensure the production of stable and effective APIs.
Controlled Reaction Conditions
Precise temperature, solvent selection, and reaction parameters are required during synthesis.
Impurity Control
Pharmaceutical-grade Acebrophylline must meet strict impurity limits according to pharmacopeia standards.
Quality Testing
Advanced analytical techniques such as:
HPLC
GC
Spectroscopy
Stability testing
are used to ensure consistent API quality.
Global Market Demand for Acebrophylline
Respiratory diseases are increasing worldwide due to:
Air pollution
Smoking
Urbanization
Environmental allergens
This has led to growing demand for effective respiratory APIs like Acebrophylline in both developed and emerging pharmaceutical markets.
Pharmaceutical manufacturers rely on trusted API suppliers to ensure uninterrupted supply and consistent quality for their formulations.
Acebrophylline API Manufacturer and Supplier
Swapnroop Drugs & Pharmaceuticals is a trusted manufacturer, exporter, and supplier of high-quality pharmaceutical APIs, including Acebrophylline.
Our company focuses on delivering high purity, consistent quality, and regulatory-compliant APIs to pharmaceutical manufacturers worldwide.
Why Choose Swapnroop Drugs & Pharmaceuticals?
WHO-GMP manufacturing standards
High purity pharmaceutical APIs
Reliable batch consistency
Regulatory documentation support
Competitive pricing
Global supply capability
We support pharmaceutical companies, formulation manufacturers, research organizations, and distributors across domestic and international markets.
1. What is Acebrophylline and how is it used in respiratory medicine?
Acebrophylline is a widely used pharmaceutical compound belonging to the class of bronchodilators and mucoregulators. It plays an important role in the treatment and management of respiratory disorders such as bronchial asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis, and other airway inflammatory conditions. Acebrophylline is particularly valued in respiratory medicine because it combines two important therapeutic properties: bronchodilation and mucus regulation.
Chemically, Acebrophylline is a derivative formed from theophylline and ambroxol. Theophylline is a well-known bronchodilator that helps relax the smooth muscles of the bronchial airways, allowing them to widen and facilitate better airflow. Ambroxol, on the other hand, is a mucolytic agent that reduces the thickness and viscosity of mucus in the respiratory tract. By combining these two mechanisms into one compound, Acebrophylline offers a unique therapeutic advantage for patients suffering from respiratory conditions where both airway constriction and mucus accumulation are present.
In respiratory diseases such as asthma and COPD, the airways become inflamed and narrowed, making it difficult for patients to breathe properly. In addition, excessive mucus production can block the air passages, further worsening breathing difficulties. Acebrophylline helps address both of these problems simultaneously by relaxing bronchial muscles and helping clear mucus from the lungs.
2. How does Acebrophylline work in the human body?
Acebrophylline works in the human body through a multi-mechanism approach that targets the major causes of respiratory distress. Unlike traditional bronchodilators that focus only on relaxing airway muscles, Acebrophylline provides a combination of bronchodilator, mucolytic, and anti-inflammatory effects, making it particularly effective for chronic respiratory conditions.
One of the primary mechanisms of Acebrophylline is bronchodilation. In respiratory diseases such as asthma and COPD, the smooth muscles surrounding the bronchial tubes become constricted. This narrowing of airways restricts airflow and makes breathing difficult. Acebrophylline helps relax these muscles, causing the bronchial tubes to widen. As a result, airflow to the lungs improves and patients experience relief from symptoms such as wheezing, chest tightness, and shortness of breath.
Another key function of Acebrophylline is its mucolytic action. Respiratory diseases often lead to excessive production of thick mucus in the airways. This mucus can accumulate in the lungs and block airflow, causing coughing and breathing difficulty. Acebrophylline reduces the viscosity of mucus, making it thinner and easier to expel from the respiratory tract. By improving mucus clearance, the drug helps maintain clear airways and enhances lung ventilation.
Conclusion
Acebrophylline plays a critical role in modern respiratory therapy by combining bronchodilator, anti-inflammatory, and mucolytic properties in a single molecule. Its effectiveness in treating asthma, COPD, and chronic bronchitis has made it a widely used API in respiratory medicines.
With increasing respiratory health challenges worldwide, the demand for high-quality Acebrophylline API continues to grow.
Swapnroop Drugs & Pharmaceuticals remains committed to supplying premium-quality pharmaceutical APIs to support safe, effective, and affordable healthcare solutions globally.
Swapnroop Drugs & Pharmaceuticals
🌐 www.sdp.org.in
✉️ sales@sdp.org.in
📞 +91-8767062101
Comments
Post a Comment